Long-term prazosin therapy for COPD pulmonary hypertension.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1643964.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 51-year-old patient with COPD, obesity, and pulmonary hypertension underwent long-term prazosin therapy after a successful hemodynamic response to 1 mg of oral prazosin. The 18-month administration of prazosin, in a dose of 3 mg a day, resulted in continued hemodynamic and echocardiographic benefits.
Medical subject headings
- Hypertension, Pulmonary
- Lung Diseases, Obstructive
- Prazosin